Navigation Links
First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive
Date:12/16/2009

ranging between $500 million and $750 million from 2011 to 2015. If you add the additional applications such as facelift, breast reconstruction and body contouring that we will pursue with TissuGlu, the opportunity increases to between $700 million to more than $1 billion over the same five-year period."

Chad Coberly, J.D., vice president of clinical, regulatory and legal affairs of Cohera Medical, added: "Initiation of this study culminates significant preclinical work by our company and investigators and demonstrates the primary safety profile of this product. This study will enable us to move closer to CE Mark application in Europe and will provide important data in application for a larger U.S.-based trial in 2010."

Preclinical data published in the July 2008 issue of Plastic and Reconstructive Surgery show that TissuGlu prevented seroma formation in an animal abdominoplasty model. Summarized in a paper titled "Lysine-Derived Urethane Surgical Adhesive Prevents Seroma Formation in a Canine Abdominoplasty Model," (Plast. Reconstr. Surg. 2008; Vol. 122, Issue 1: 95-102) the results demonstrated that TissuGlu successfully prevented the formation of seroma in a novel large-animal model designed to evaluate seroma formation. While the control side in all seven animals used in the study demonstrated large, clinically significant seromas, the side treated with TissuGlu showed little or no evidence of fluid accumulation. In addition, histologic analysis of tissue samples from the animals showed no signs of inflammation or foreign body reaction associated with the adhesive.

"The progress with the development of TissuGlu represents a significant next step in the value creation for Cohera Medical's investors," said Doros Platika, M.D., the company's chairman. "Most importantly, it signifies a potential major advance for surgical patients that may help to decrease complications and improve clinical outcomes." '/>"/>

SOURCE Cohera Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... 2015  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) will ... on Wednesday, May 6, 2015, following the close of the ... conference call and live webcast on the same day at ... discuss the financial results.  To access the ... the "Investors" link.  Please log onto the webcast prior to ...
(Date:4/16/2015)... Kenneth C. Frazier , chairman and chief executive officer ... the Board of the Pharmaceutical Research and Manufacturers of America ... John J. Castellani announced that he will be retiring ... to PhRMA Board Frazier formerly held the position ... and CEO of Pfizer, Inc. Also elected were George ...
(Date:4/16/2015)... YORK , April 16, 2015 An ... additional way to generate trimers from the major HIV ... could benefit future clinical development of HIV vaccine candidates ... the critical target on the surface of HIV for ... an important platform for AIDS vaccine discovery, says ...
Breaking Medicine Technology:Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 4Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 5New Method Holds Promise for HIV Vaccine Development 2
... Corporation (Nasdaq: GNBT, www.generex.com ), the leader in ... of the mouth, today announced that it has been ... Canadian Intellectual Property Office granted Canadian Patent No. 2,401,942, ... Application". This new patent increases the number ...
... International Corporation (Nasdaq: PRXL ) announced today it ... Conference in New York.  James Winschel, Senior Vice President and ... at 11:45 a.m. ET on Tuesday, October 5, 2010. ... through the "Investors" section of PAREXEL,s website at ...
Cached Medicine Technology:Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System 2Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System 3PAREXEL International to Present at William Blair Emerging Growth Stock Conference 2
(Date:4/19/2015)... 2015 A live auction will be held ... major hospital in Brooklyn, NY and other national consignors. Various ... lab, anesthesia, exam and much more. , The auction ... starting at 9:00am CDT each day. The equipment is at ... Park, IL 60160. Anyone can participate in the auction ...
(Date:4/19/2015)... (PRWEB) April 19, 2015 Family and friends ... for Brains in Memory of Brad Baddeley event to ... Aneurysm Foundation. , Bowling for Brains is cheduled to take ... 4700 Dudley Street in Lincoln, Nebraska. Participants may arrive at ... to 3:00pm. , The cost is only $4 per game ...
(Date:4/18/2015)... New York, NY (PRWEB) April 19, 2015 ... has experienced strong growth during the past five years. ... elderly individuals who are unable to fully care for ... and the growing need for dementia care for seniors ... revenue to rise at an annualized rate of 4.1% ...
(Date:4/18/2015)... Carinsurancesavings.biz has released a new blog post explaining why ... , Spring can be a great season for ... they compare the newest policies before deciding on a ... Spring car insurance offers by reading the newly released ... more and more popular. Many insurance brokerage websites like ...
(Date:4/18/2015)... April 18, 2015 "I wanted ... to create a healthful juice that contained essential ... Rosedale, Md. "It increases my energy, improves skin ... , He developed Tapp's Juice to contain fruits, ... to prevent physical and mental fatigue. It features ...
Breaking Medicine News(10 mins):Health News:Centurion to Sell Surplus Medical Equipment in Online and On-Site Auction 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Auto Insurance Plans Are Cheaper During Spring! 2
... Facet Solutions, Inc. announced,today that it has ... of,patients to receive its Anatomic Facet Replacement System ... year include a significant,decline in leg and back ... Additionally, the first patient in the,AFRS(TM) study has ...
... Symbol: AKL, MONTREAL, Oct. 15 /PRNewswire-FirstCall/ - ... focused on developing therapies for the,inhalation and pain ... offering in the United States of 5,250,000 shares ... a 30-day option to purchase up to,an additional ...
... study published in the October 15 issue of the ... Adolescent Sleepiness Questionnaire (CASQ), a new self-completed instrument to ... led by James C. Spilsbury, PhD, of the Division ... on a subsample of 411 adolescents between 11-17 years ...
... US$ 65 M (About Euro 46 M),Frutarom Establishes its Position as One of ... ... Frutarom Continues to Implement Rapid Growth Strategy, ... ("Frutarom") announced today,that it has signed an agreement to acquire 100% of the ...
... in 3 Believe Nothing Can Be Done, 2 ... Risk to Well-Being, CHICAGO, Oct. 15 Nearly ... to prevent accidental injuries, posing a major,obstacle to national ... according to a national survey of American attitudes on,safety ...
... STANFORD, Calif. - One of the most distressing aspects of ... problems are the beginning of an inevitable mental decline. Researchers ... blood test that is a step toward giving people an ... of the disease. , The test identifies changes in a ...
Cached Medicine News:Health News:Facet Solution's AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up 2Health News:AKELA Pharma Inc. announces U.S. public offering and proposed listing 2Health News:New tool to assess excessive daytime sleepiness in adolescents published in JCSM 2Health News:Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors 2Health News:Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors 3Health News:Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors 4Health News:Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors 5Health News:Americans' Pessimistic View of Accident Prevention Poses Hurdle to Reducing Injuries, Survey Says 2Health News:Americans' Pessimistic View of Accident Prevention Poses Hurdle to Reducing Injuries, Survey Says 3Health News:Blood test takes step toward predicting Alzheimer's risk, Stanford researchers find 2Health News:Blood test takes step toward predicting Alzheimer's risk, Stanford researchers find 3Health News:Blood test takes step toward predicting Alzheimer's risk, Stanford researchers find 4
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
... The Vivid 3 system is designed ... of cardiovascular performance, and offer an even ... pediatrics and the OR. From color flow ... connectivity, the new Vivid 3 offers a ...
... 4 system is an easy-to-use, high-performance ultrasound ... your clinical practice. In effect, GE has ... a value-based combination of proven technology and ... paid heed to features praised by Vivid ...
... remote monitoring from Medtronic is changing the ... care. Using their Medtronic CareLink Monitor and ... send device information from their home or ... site, clinicians have the ability to review ...
Medicine Products: